Nathan A. Vandergrift, Ph.D. - Publications

Affiliations: 
2004 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Psychometrics Psychology

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Felber BK, Lu Z, Hu X, Valentin A, Rosati M, Remmel CAL, Weiner JA, Carpenter MC, Faircloth K, Stanfield-Oakley S, Williams WB, Shen X, Tomaras GD, LaBranche CC, Montefiori D, ... ... Vandergrift NA, et al. Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. Cell Reports. 31: 107624. PMID 32402293 DOI: 10.1016/J.Celrep.2020.107624  0.458
2020 Han Q, Bradley T, Williams WB, Cain DW, Montefiori DC, Saunders KO, Parks RJ, Edwards RW, Ferrari G, Mueller O, Shen X, Wiehe KJ, Reed S, Fox CB, Rountree W, ... Vandergrift NA, et al. Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization. Cell Reports. 30: 1553-1569.e6. PMID 32023469 DOI: 10.1016/J.Celrep.2019.12.091  0.476
2018 Nelson CS, Cruz DV, Su M, Xie G, Vandergrift N, Pass RF, Forman M, Diener-West M, Koelle K, Arav-Boger R, Permar SR. Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees. Journal of Virology. PMID 30518646 DOI: 10.1128/Jvi.01695-18  0.397
2018 Blasi M, Negri D, LaBranche C, Alam SM, Baker EJ, Brunner EC, Gladden MA, Michelini Z, Vandergrift NA, Wiehe KJ, Parks R, Shen X, Bonsignori M, Tomaras GD, Ferrari G, et al. IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells. Communications Biology. 1: 134. PMID 30272013 DOI: 10.1038/s42003-018-0131-6  0.473
2018 Bradley T, Peppa D, Pedroza-Pacheco I, Li D, Cain DW, Henao R, Venkat V, Hora B, Chen Y, Vandergrift NA, Overman RG, Edwards RW, Woods CW, Tomaras GD, Ferrari G, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. PMID 30270043 DOI: 10.1016/J.Cell.2018.08.064  0.535
2018 Himes JE, Goswami R, Mangan RJ, Kumar A, Jeffries TL, Eudailey JA, Heimsath H, Nguyen QN, Pollara J, LaBranche C, Chen M, Vandergrift NA, Peacock JW, Schiro F, Midkiff C, et al. Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys. Mucosal Immunology. PMID 30115994 DOI: 10.1038/S41385-018-0067-7  0.515
2018 Nelson CS, Huffman T, Jenks JA, Cisneros de la Rosa E, Xie G, Vandergrift N, Pass RF, Pollara J, Permar SR. HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions. Proceedings of the National Academy of Sciences of the United States of America. PMID 29712861 DOI: 10.1073/Pnas.1800177115  0.438
2018 Nguyen QN, Martinez DR, Himes JE, Whitney Edwards R, Han Q, Kumar A, Mangan R, Nicely NI, Xie G, Vandergrift N, Shen X, Pollara J, Permar SR. Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys. Retrovirology. 15: 24. PMID 29523166 DOI: 10.1186/S12977-018-0406-5  0.473
2018 Saunders KO, Santra S, Parks R, Yates NL, Sutherland LL, Scearce RM, Balachandran H, Bradley T, Goodman D, Eaton A, Stanfield-Oakley SA, Tartaglia J, Phogat S, Pantaleo G, Esteban M, ... ... Vandergrift N, et al. Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates. Journal of Virology. PMID 29437967 DOI: 10.1128/Jvi.02035-17  0.577
2017 Seaton KE, Vandergrift NA, Deal AW, Rountree W, Bainbridge J, Grebe E, Anderson DA, Sawant S, Shen X, Yates NL, Denny TN, Liao HX, Haynes BF, Robb ML, Parkin N, et al. Computational analysis of antibody dynamics identifies recent HIV-1 infection. Jci Insight. 2. PMID 29263306 DOI: 10.1172/Jci.Insight.94355  0.548
2017 Williams WB, Zhang J, Jiang C, Nicely NI, Fera D, Luo K, Moody MA, Liao HX, Alam SM, Kepler TB, Ramesh A, Wiehe K, Holland JA, Bradley T, Vandergrift N, et al. Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations. Nature Communications. 8: 1732. PMID 29170366 DOI: 10.1038/S41467-017-01336-3  0.544
2017 Yu JS, Liao HX, Pritchett J, Bowman C, Vivian C, Parks R, Xia SM, Cooper M, Williams WB, Bonsignori M, Reed SG, Chen M, Vandergrift N, Rice CM, Haynes BF. Development of a Recombinant Yellow Fever Vector Expressing a HIV Clade C Founder Envelope gp120. Journal of Virological Methods. PMID 28837840 DOI: 10.1016/J.Jviromet.2017.08.012  0.552
2017 Han Q, Williams WB, Saunders KO, Seaton KE, Wiehe KJ, Vandergrift N, Von Holle T, Trama AM, Parks RJ, Luo K, Gurley TC, Kepler TB, Marshall DJ, Montefiori DC, Sutherland LL, et al. HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques. Journal of Virology. PMID 28794027 DOI: 10.1128/Jvi.00923-17  0.544
2017 Nelson CS, Cruz DV, Tran D, Bialas KM, Stamper L, Wu H, Gilbert M, Blair R, Alvarez X, Itell H, Chen M, Deshpande A, Chiuppesi F, Wussow F, Diamond DJ, ... Vandergrift N, et al. Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys. Jci Insight. 2. PMID 28679960 DOI: 10.1172/Jci.Insight.94002  0.392
2017 Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, et al. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. Nature Communications. 8: 15711. PMID 28593989 DOI: 10.1038/Ncomms15711  0.544
2017 Mutucumarana CP, Eudailey J, McGuire EP, Vandergrift N, Tegha G, Chasela C, Ellington S, van der Horst C, Kourtis AP, Permar SR, Fouda GG. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals. Clinical and Vaccine Immunology : Cvi. PMID 28566336 DOI: 10.1128/Cvi.00062-17  0.538
2017 Easterhoff D, Moody MA, Fera D, Cheng H, Ackerman M, Wiehe K, Saunders KO, Pollara J, Vandergrift N, Parks R, Kim J, Michael NL, O'Connell RJ, Excler JL, Robb ML, et al. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. Plos Pathogens. 13: e1006182. PMID 28235027 DOI: 10.1371/Journal.Ppat.1006182  0.553
2017 Martinez DR, Vandergrift N, Douglas AO, McGuire E, Bainbridge J, Nicely NI, Montefiori DC, Tomaras GD, Fouda GG, Permar SR. Maternal binding and neutralizing IgG responses targeting the C terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk. Journal of Virology. PMID 28202762 DOI: 10.1128/Jvi.02422-16  0.543
2016 Moody MA, Pedroza-Pacheco I, Vandergrift NA, Chui C, Lloyd KE, Parks R, Soderberg KA, Ogbe AT, Cohen MS, Liao HX, Gao F, McMichael AJ, Montefiori DC, Verkoczy L, Kelsoe G, et al. Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies. Science Immunology. 1: aag0851. PMID 28783677 DOI: 10.1126/Sciimmunol.Aag0851  0.551
2016 Luo K, Liao HX, Zhang R, Easterhoff D, Wiehe K, Gurley TC, Armand LC, Allen AA, Von Holle TA, Marshall DJ, Whitesides JF, Pritchett J, Foulger A, Hernandez G, Parks R, ... ... Vandergrift NA, et al. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques. Jci Insight. 1: e88522. PMID 27942585 DOI: 10.1172/Jci.Insight.88522  0.42
2016 Bradley T, Yang G, Ilkayeva O, Holl TM, Zhang R, Zhang J, Santra S, Fox CB, Reed SG, Parks R, Bowman CM, Bouton-Verville H, Sutherland LL, Scearce RM, Vandergrift N, et al. HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism. Journal of Immunology (Baltimore, Md. : 1950). PMID 27849170 DOI: 10.4049/Jimmunol.1601484  0.504
2016 Zhang R, Martinez DR, Nguyen QN, Pollara J, Arifin T, Stolarchuk C, Foulger A, Amos JD, Parks R, Himes JE, Wang M, Edwards RW, Trama AM, Vandergrift N, Colvin L, et al. Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus. Nature Communications. 7: 12131. PMID 27381634 DOI: 10.1038/Ncomms12131  0.558
2016 Zhang R, Verkoczy L, Wiehe K, Munir Alam S, Nicely NI, Santra S, Bradley T, Pemble CW, Zhang J, Gao F, Montefiori DC, Bouton-Verville H, Kelsoe G, Larimore K, Greenberg PD, ... ... Vandergrift N, et al. Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages. Science Translational Medicine. 8: 336ra62. PMID 27122615 DOI: 10.1126/Scitranslmed.Aaf0618  0.509
2015 Moody MA, Gao F, Gurley TC, Amos JD, Kumar A, Hora B, Marshall DJ, Whitesides JF, Xia SM, Parks R, Lloyd KE, Hwang KK, Lu X, Bonsignori M, Finzi A, ... Vandergrift NA, et al. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses. Cell Host & Microbe. 18: 354-62. PMID 26355218 DOI: 10.1016/J.Chom.2015.08.006  0.523
2015 Williams WB, Liao HX, Moody MA, Kepler TB, Alam SM, Gao F, Wiehe K, Trama AM, Jones K, Zhang R, Song H, Marshall DJ, Whitesides JF, Sawatzki K, Hua A, ... ... Vandergrift N, et al. HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science (New York, N.Y.). 349: aab1253. PMID 26229114 DOI: 10.1126/Science.Aab1253  0.555
2015 Permar SR, Fong Y, Vandergrift N, Fouda GG, Gilbert P, Parks R, Jaeger FH, Pollara J, Martelli A, Liebl BE, Lloyd K, Yates NL, Overman RG, Shen X, Whitaker K, et al. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission. The Journal of Clinical Investigation. 125: 2702-6. PMID 26053661 DOI: 10.1172/Jci81593  0.543
2015 Chen Y, Li N, Zhang T, Huang X, Cai F, Vandergrift N, Xin R, Meng Z, Zhang X, Jiang C, Xu X, Montefiori DC, Gao F, Wu H. Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 403-12. PMID 25886933 DOI: 10.1097/Qai.0000000000000649  0.373
2015 Hulot SL, Korber B, Giorgi EE, Vandergrift N, Saunders KO, Balachandran H, Mach LV, Lifton MA, Pantaleo G, Tartaglia J, Phogat S, Jacobs B, Kibler K, Perdiguero B, Gomez CE, et al. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. Journal of Virology. 89: 6462-80. PMID 25855741 DOI: 10.1128/Jvi.00383-15  0.532
2015 Liu M, Yang G, Wiehe K, Nicely NI, Vandergrift NA, Rountree W, Bonsignori M, Alam SM, Gao J, Haynes BF, Kelsoe G. Polyreactivity and autoreactivity among HIV-1 antibodies. Journal of Virology. 89: 784-98. PMID 25355869 DOI: 10.1128/Jvi.02378-14  0.519
2015 Fouda GG, Cunningham CK, McFarland EJ, Borkowsky W, Muresan P, Pollara J, Song LY, Liebl BE, Whitaker K, Shen X, Vandergrift NA, Overman RG, Yates NL, Moody MA, Fry C, et al. Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. The Journal of Infectious Diseases. 211: 508-17. PMID 25170104 DOI: 10.1093/Infdis/Jiu444  0.495
2015 Sacha CR, Vandergrift N, Jeffries TL, McGuire E, Fouda GG, Liebl B, Marshall DJ, Gurley TC, Stiegel L, Whitesides JF, Friedman J, Badiabo A, Foulger A, Yates NL, Tomaras GD, et al. Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women. Mucosal Immunology. 8: 316-26. PMID 25100291 DOI: 10.1038/Mi.2014.69  0.569
2015 Moody MA, Gao F, Gurley TC, Amos JD, Kumar A, Hora B, Marshall DJ, Whitesides JF, Xia SM, Parks R, Lloyd KE, Hwang KK, Lu X, Bonsignori M, Finzi A, ... Vandergrift NA, et al. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses Cell Host and Microbe. 18: 354-362. DOI: 10.1016/j.chom.2015.08.006  0.336
2014 Trama AM, Moody MA, Alam SM, Jaeger FH, Lockwood B, Parks R, Lloyd KE, Stolarchuk C, Scearce R, Foulger A, Marshall DJ, Whitesides JF, Jeffries TL, Wiehe K, Morris L, ... ... Vandergrift N, et al. HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria. Cell Host & Microbe. 16: 215-26. PMID 25121750 DOI: 10.1016/J.Chom.2014.07.003  0.548
2014 Dennison SM, Anasti KM, Jaeger FH, Stewart SM, Pollara J, Liu P, Kunz EL, Zhang R, Vandergrift N, Permar S, Ferrari G, Tomaras GD, Bonsignori M, Michael NL, Kim JH, et al. Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide. Journal of Virology. 88: 9406-17. PMID 24920809 DOI: 10.1128/Jvi.01031-14  0.555
2014 Payne TL, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift NA, Freel SA, Ferrari G, Keene JD, Tomaras GD. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. Journal of Virology. 88: 9514-28. PMID 24899193 DOI: 10.1128/Jvi.00802-14  0.451
2014 Yates NL, Liao HX, Fong Y, deCamp A, Vandergrift NA, Williams WT, Alam SM, Ferrari G, Yang ZY, Seaton KE, Berman PW, Alpert MD, Evans DT, O'Connell RJ, Francis D, et al. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Science Translational Medicine. 6: 228ra39. PMID 24648342 DOI: 10.1126/Scitranslmed.3007730  0.555
2014 Liu P, Williams LD, Shen X, Bonsignori M, Vandergrift NA, Overman RG, Moody MA, Liao HX, Stieh DJ, McCotter KL, French AL, Hope TJ, Shattock R, Haynes BF, Tomaras GD. Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity. Journal of Virology. 88: 5165-70. PMID 24554654 DOI: 10.1128/Jvi.03765-13  0.512
2014 Moody MA, Santra S, Vandergrift NA, Sutherland LL, Gurley TC, Drinker MS, Allen AA, Xia SM, Meyerhoff RR, Parks R, Lloyd KE, Easterhoff D, Alam SM, Liao HX, Ward BM, et al. Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. Journal of Virology. 88: 3329-39. PMID 24390332 DOI: 10.1128/Jvi.03309-13  0.444
2013 Carias AM, McCoombe S, McRaven M, Anderson M, Galloway N, Vandergrift N, Fought AJ, Lurain J, Duplantis M, Veazey RS, Hope TJ. Defining the Interaction of HIV-1 with the Mucosal Barriers of the Female Reproductive Tract Journal of Virology. 87: 11388-11400. PMID 23966398 DOI: 10.1128/Jvi.01377-13  0.504
2013 Liao HX, Tsao CY, Alam SM, Muldoon M, Vandergrift N, Ma BJ, Lu X, Sutherland LL, Scearce RM, Bowman C, Parks R, Chen H, Blinn JH, Lapedes A, Watson S, et al. Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1. Journal of Virology. 87: 4185-201. PMID 23365441 DOI: 10.1128/Jvi.02297-12  0.533
2013 Fouda GG, Mahlokozera T, Salazar-Gonzalez JF, Salazar MG, Learn G, Kumar SB, Dennison SM, Russell E, Rizzolo K, Jaeger F, Cai F, Vandergrift NA, Gao F, Hahn B, Shaw GM, et al. Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants. Retrovirology. 10: 3. PMID 23305422 DOI: 10.1186/1742-4690-10-3  0.435
2013 Yates NL, Stacey AR, Nolen TL, Vandergrift NA, Moody MA, Montefiori DC, Weinhold KJ, Blattner WA, Borrow P, Shattock R, Cohen MS, Haynes BF, Tomaras GD. HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. Mucosal Immunology. 6: 692-703. PMID 23299618 DOI: 10.1038/Mi.2012.107  0.555
2012 Moody MA, Yates NL, Amos JD, Drinker MS, Eudailey JA, Gurley TC, Marshall DJ, Whitesides JF, Chen X, Foulger A, Yu JS, Zhang R, Meyerhoff RR, Parks R, Scull JC, ... ... Vandergrift NA, et al. HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages. Journal of Virology. 86: 7496-507. PMID 22553329 DOI: 10.1128/Jvi.00426-12  0.563
2012 Trama A, Liao H, Foulger A, Marshall D, Whitesides J, Parks R, Meyerhoff R, Lloyd K, Donathan M, Lucas J, Soderberg K, Kepler T, Vandergrift N, Yates N, Tomaras G, et al. Lack of IgA envelope-reactive antibody producing cells in terminal ileum in early and chronic HIV-1 infection Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-P201  0.58
2011 Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, Whitesides JF, Drinker MS, Amos JD, Gurley TC, Eudailey JA, ... ... Vandergrift NA, et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. Plos One. 6: e25797. PMID 22039424 DOI: 10.1371/Journal.Pone.0025797  0.375
2011 Liao HX, Chen X, Munshaw S, Zhang R, Marshall DJ, Vandergrift N, Whitesides JF, Lu X, Yu JS, Hwang KK, Gao F, Markowitz M, Heath SL, Bar KJ, Goepfert PA, et al. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated Journal of Experimental Medicine. 208: 2237-2249. PMID 21987658 DOI: 10.1084/Jem.20110363  0.555
2011 Liu P, Overman RG, Yates NL, Alam SM, Vandergrift N, Chen Y, Graw F, Freel SA, Kappes JC, Ochsenbauer C, Montefiori DC, Gao F, Perelson AS, Cohen MS, Haynes BF, et al. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. Journal of Virology. 85: 11196-207. PMID 21865397 DOI: 10.1128/Jvi.05601-11  0.545
2011 Yates NL, Lucas JT, Nolen TL, Vandergrift NA, Soderberg KA, Seaton KE, Denny TN, Haynes BF, Cohen MS, Tomaras GD. Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. Aids (London, England). 25: 2089-97. PMID 21832938 DOI: 10.1097/Qad.0B013E32834B348E  0.553
2009 Bonsignori M, Moody MA, Parks RJ, Holl TM, Kelsoe G, Hicks CB, Vandergrift N, Tomaras GD, Haynes BF. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection. Journal of Immunology (Baltimore, Md. : 1950). 183: 2708-17. PMID 19625640 DOI: 10.4049/Jimmunol.0901068  0.542
2009 Levesque MC, Moody MA, Hwang KK, Marshall DJ, Whitesides JF, Amos JD, Gurley TC, Allgood S, Haynes BB, Vandergrift NA, Plonk S, Parker DC, Cohen MS, Tomaras GD, Goepfert PA, et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. Plos Medicine. 6: e1000107. PMID 19582166 DOI: 10.1371/Journal.Pmed.1000107  0.555
2009 Bonsignori M, Moody M, Parks R, Holl T, Kelsoe G, Hicks C, Vandergrift N, Tomaras G, Haynes B. P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection Retrovirology. 6: 76. DOI: 10.1186/1742-4690-6-S3-P76  0.566
2009 Bonsignori M, Hwang K, Vandergrift N, Moody M, Haynes B. P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay Retrovirology. 6: 29. DOI: 10.1186/1742-4690-6-S3-P29  0.52
2007 Willoughby M, Vandergrift N, Blair C, Granger DA. A Structural Equation Modeling Approach for the Analysis of Cortisol Data Collected Using Pre–Post–Post Designs Structural Equation Modeling: a Multidisciplinary Journal. 14: 125-145. DOI: 10.1080/10705510709336740  0.485
Show low-probability matches.